The global adhesion barrier market was valued at USD 859.95 million in 2022 and is projected to reach USD 1.50 billion by 2030, exhibiting a CAGR of 7.3% from 2023 to 2030. The market's growth is driven by a rising geriatric population and an increasing number of surgical procedures, particularly invasive surgeries with a high risk of postoperative complications.
Despite this growth, the market faces challenges related to accessibility, a lack of health education, and a general lack of awareness about the importance of treatment for post-operation adhesions. However, several factors are expected to drive significant market growth, including improvements in healthcare infrastructure, the increasing availability of trauma care centers, and a growing incidence of sports-related injuries. Recent data from Stanford Children's Health indicates that over 10% of the approximately 30 million children who participate in sports each year experience injuries.
Key Market Trends & Insights
- North America dominated the market in 2022, holding the largest revenue share. This is attributed to the presence of major players like Johnson & Johnson and Baxter International, as well as a high prevalence of orthopedic conditions and the adoption of advanced treatment procedures in the U.S.
- Based on product, synthetic adhesion barriers accounted for the largest market size due to their high bioresorbability, biocompatibility, and cost-effectiveness. The widespread availability of commercial synthetic barriers also contributes to their dominance.
- By formulation, the film/mesh segment held the largest market share in 2022 and is expected to maintain its dominance. This is due to their low cost and increasing use in various surgical procedures.
- In terms of application, cardiovascular surgeries dominated the market and are projected to grow at the fastest CAGR. This growth is driven by the rising incidence of heart-related diseases and the increasing use of adhesion barriers in these procedures. A 2020 study in the Annals of Medicine and Surgery also noted the benefits of adhesion barriers in preventing peristomal adhesion.
Order a free sample PDF of the Adhesion Barrier Market Intelligence Study, published by Grand View Research.
Market Size & Forecast
- 2022 Market Size: USD 859.95 million
- 2030 Projected Market Size: USD 1.50 billion
- CAGR (2023 to 2030): 7.3%
- North America: Largest market in 2022
Key Companies & Market Share Insights
Companies are employing strategies such as product launches, mergers & acquisitions, and partnerships to maintain their market share. For example, Gunze launched the TENALEAF absorbable adhesion barrier in Japan in 2022, a move aimed at expanding its product portfolio and strengthening its competitive position.
Key Players
- Sanofi S.A.
- Becton Dickinson and Company
- Baxter International, Inc.
- Johnson & Johnson
- Anika Therapeutic, Inc.
- FzioMed, Inc,
- Mast Biosurgery, Inc.,
- Innocoll Holdings PLC
- Atrium Medical Corporation (A part of Getinge Group).
Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.
Conclusion
The adhesion barrier market is poised for significant growth, driven by a global increase in surgical procedures and specific health conditions. While challenges like a lack of awareness persist, the market's trajectory is positive due to key factors like improvements in healthcare infrastructure and strategic moves by major companies. Synthetic barriers and film/mesh formulations are leading the market, with cardiovascular surgeries being a key application area for future growth.